Clinical Trials on Coronavirus Infections in New Zealand

Total 6558 results

Nakhle Saba, MD

No longer available

Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19

COVID-19

United States
St. Francis Hospital, New York

Completed

Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting

COVID-19

United States
NYU Langone Health

Completed

COVID-19 PrEP HCW HCQ Study

COVID-19

United States
Max Healthcare Insititute Limited

Unknown

Assess the Seroconversion Status of Health Care Workers Suspected or Confirmed Cases of COVID-19 Patients

Covid-19

India
EVIVE Biotechnology

Terminated

Study of F-652 (IL-22:IgG2 Fusion Protein) in Patients With Moderate to Severe COVID-19

Covid19

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of N-acetylcysteine in Patients With COVID-19 Infection

Covid-19

United States
Emergent BioSolutions
United States Department of Defense

Completed

A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults

COVID-19

United States
Max Healthcare Insititute Limited

Unknown

Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications

COVID 19

India
University of New Mexico

Terminated

Non-comparative Trial of the Combination of HCQ and AZI in the Treatment of ICU Patients

COVID-19

United States
State University of New York at Buffalo
National Center for Advancing Translational Sciences (NCATS)

Withdrawn

Dose-Ranging Study to Assess the Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19

COVID-19

United States
NYU Langone Health
State University of New York - Downstate Medical Center

Terminated

Treating COVID-19 With Hydroxychloroquine (TEACH)

COVID-19

United States
LCMC Health

Terminated

Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease (RCT)

COVID-19

United States
Columbia University

Terminated

Sensitivity of Frequent SARS-CoV-2 (COVID-19) Rapid Antigen Testing Regimen

Covid19

United States
Columbia University
New York State Psychiatric Institute

Completed

Social Activity, Loneliness and Stigma During COVID-19 Outbreak

Covid19 | Fear | Loneliness

United States
Shionogi

Recruiting

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection (SCORPIO-PEP)

SARS-CoV-2 Infection

Japan, United States
BioNTech SE
Pfizer

Completed

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

COVID-19 | SARS-CoV-2 Infection

United States
Pfizer

Active, not recruiting

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

COVID-19 | Influenza, Human | SARS-CoV-2 Infection

United States
Alios Biopharma Inc.

Completed

A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Ascending Doses Including Food Effect Evaluation; After Multi-Day Dosing in Healthy Participants; and After Multiple (Ascending) Doses in Participants With Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of, Moldova, Republic of, New Zealand, Thailand, Ukraine
Max Healthcare Insititute Limited

Unknown

Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic

Oncology Patients

India
Louisiana State University Health Sciences Center...
Innovate Anti-Infectives

Recruiting

Outpatient Liquid Aspirin (OLA) (OLA COVID)

Covid19

United States
Mach-E B.V.

Completed

Study Utilizing BIOZEK COVID-19 Antigen Rapid Test.

Covid19

United States
Frontier Biotechnologies Inc.

Completed

The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 Infection

Covid19

United States
Tulane University
Gilead Sciences

Completed

Real World Study of COVID-19 in a Flyover Region

Covid19

United States
Yale University

Completed

COVID-19 Vaccine Messaging, Part 1

COVID-19 | Vaccination

United States
Histogen

Terminated

Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19

Covid19

United States
drpykessupplements.com

Withdrawn

Remotely-conducted Trial of Famotidine vs Placebo for Patients at Home With Coronavirus (COVID) of 2019 (COVID-19) (Pepcid4COV19)

Covid19

United States
New York University

Recruiting

Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers

COVID-19 | COVID-19 Testing

United States
Columbia University

Recruiting

Mother-infant Bonding During COVID-19

Child Development | Mother-Infant Interaction | Relation, Parent-Child

United States
Columbia University
Merck Sharp & Dohme LLC

Completed

Acceptability of a COVID-19 Vaccine Among US Adults Over Two Time Periods

Covid19 | Vaccine Acceptability

United States
Max Healthcare Insititute Limited

Unknown

Anxiety And Depression During COVID-19 IN INDIA

COVID-19

India
Yale University
Food and Drug Administration (FDA)

Active, not recruiting

Yale COVID-19 Recovery Study

Covid19 Sequelae

United States
Pfizer

Completed

This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times.

COVID-19 | Influenza, Human

United States
Ansun Biopharma, Inc.

Recruiting

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

COVID-19 | Lower Respiratory Tract Infection | Immunocompromised | Parainfluenza

United States, Australia, China, Denmark, France, Hong Kong, Korea, Republic of, Taiwan
University of New Mexico
National Institutes of Health (NIH); National Institute of General Medical...

Completed

The Role of Frequent Point-of-care Molecular Workplace Surveillance for Miners

Covid19

United States
Hackensack Meridian Health

Completed

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

Covid19

United States
BioNTech SE
Pfizer

Completed

A Study to Evaluate Safety, Tolerability, & Immunogenicity of Multiple Formulations of BNT162b2 Against COVID-19 in Healthy Adults

COVID-19 | SARS-CoV-2 Infection

United States
Johns Hopkins All Children's Hospital

Completed

COVID-19 Anticoagulation in Children - Thromboprophlaxis (COVAC-TP) Trial

COVID-19 | Thromboses, Venous | Infection Viral

United States
Regeneron Pharmaceuticals

Completed

Single Ascending-dose Study of the Efficacy, Safety, Tolerability, and Pharmacokinetics of REGN1908-1909 in Allergic, Adult Participants

Allergy

United Kingdom, New Zealand, Netherlands, Sweden
BioNTech SE

Completed

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

COVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)

United States, Germany, Turkey, South Africa
Stony Brook University

Terminated

Convalescent Plasma vs. Standard Plasma for COVID-19

COVID

United States
University of Rochester

Active, not recruiting

Serologic Response to the SARS-CoV-2 (COVID-19) mRNA-1273 Vaccine in Select Subsets of Oncology Patients

Cancer | Covid19

United States
Bassett Healthcare
Bioreference, Inc

Completed

The COVID-19 PUI Reality Check (CPRC) Study (CPRC)

Covid19 Immunology

United States
University of New Mexico

Terminated

Efficacy of Hydroxychloroquine Prophylaxis for Health Care Workers at High Risk for COVID-19

COVID-19

United States
BioNTech SE
Pfizer

Completed

Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years

SARS-CoV-2 Infection, COVID19

United States, Brazil, Germany, Mexico
Yale University

Terminated

Tofacitinib for Treatment of Moderate COVID-19 (I-TOMIC)

COVID-19 Pneumonia

United States
GlaxoSmithKline

Completed

A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above

Respiratory Syncytial Virus Infections

Panama, New Zealand, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine (CoVPN 3006)

SARS-CoV-2 Infection

United States
Northwell Health
Regeneron Pharmaceuticals

Withdrawn

Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail

COVID-19 | Organ Transplant

United States
Hengenix Biotech Inc

Completed

Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects

COVID 19

United States
Feinstein Institute for Medical Research
Cold Spring Harbor Laboratory

Completed

Dornase Alfa Administered to Patients With COVID-19 (DACOVID) (DACOVID)

COVID-19 | Mechanical Ventilation

United States

3

Subscribe